_version_ 1784910458419937280
author Xue, Yibo
Morris, Jordan L.
Yang, Kangning
Fu, Zheng
Zhu, Xianbing
Johnson, Fraser
Meehan, Brian
Witkowski, Leora
Yasmeen, Amber
Golenar, Tunde
Coatham, Mackenzie
Morin, Geneviève
Monast, Anie
Pilon, Virginie
Fiset, Pierre Olivier
Jung, Sungmi
Gonzalez, Anne V.
Camilleri-Broet, Sophie
Fu, Lili
Postovit, Lynne-Marie
Spicer, Jonathan
Gotlieb, Walter H.
Guiot, Marie-Christine
Rak, Janusz
Park, Morag
Lockwood, William
Foulkes, William D.
Prudent, Julien
Huang, Sidong
author_facet Xue, Yibo
Morris, Jordan L.
Yang, Kangning
Fu, Zheng
Zhu, Xianbing
Johnson, Fraser
Meehan, Brian
Witkowski, Leora
Yasmeen, Amber
Golenar, Tunde
Coatham, Mackenzie
Morin, Geneviève
Monast, Anie
Pilon, Virginie
Fiset, Pierre Olivier
Jung, Sungmi
Gonzalez, Anne V.
Camilleri-Broet, Sophie
Fu, Lili
Postovit, Lynne-Marie
Spicer, Jonathan
Gotlieb, Walter H.
Guiot, Marie-Christine
Rak, Janusz
Park, Morag
Lockwood, William
Foulkes, William D.
Prudent, Julien
Huang, Sidong
author_sort Xue, Yibo
collection PubMed
description
format Online
Article
Text
id pubmed-10030806
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100308062023-03-23 Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria Xue, Yibo Morris, Jordan L. Yang, Kangning Fu, Zheng Zhu, Xianbing Johnson, Fraser Meehan, Brian Witkowski, Leora Yasmeen, Amber Golenar, Tunde Coatham, Mackenzie Morin, Geneviève Monast, Anie Pilon, Virginie Fiset, Pierre Olivier Jung, Sungmi Gonzalez, Anne V. Camilleri-Broet, Sophie Fu, Lili Postovit, Lynne-Marie Spicer, Jonathan Gotlieb, Walter H. Guiot, Marie-Christine Rak, Janusz Park, Morag Lockwood, William Foulkes, William D. Prudent, Julien Huang, Sidong Nat Commun Author Correction Nature Publishing Group UK 2023-03-21 /pmc/articles/PMC10030806/ /pubmed/36944611 http://dx.doi.org/10.1038/s41467-023-37144-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
Xue, Yibo
Morris, Jordan L.
Yang, Kangning
Fu, Zheng
Zhu, Xianbing
Johnson, Fraser
Meehan, Brian
Witkowski, Leora
Yasmeen, Amber
Golenar, Tunde
Coatham, Mackenzie
Morin, Geneviève
Monast, Anie
Pilon, Virginie
Fiset, Pierre Olivier
Jung, Sungmi
Gonzalez, Anne V.
Camilleri-Broet, Sophie
Fu, Lili
Postovit, Lynne-Marie
Spicer, Jonathan
Gotlieb, Walter H.
Guiot, Marie-Christine
Rak, Janusz
Park, Morag
Lockwood, William
Foulkes, William D.
Prudent, Julien
Huang, Sidong
Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria
title Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria
title_full Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria
title_fullStr Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria
title_full_unstemmed Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria
title_short Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria
title_sort author correction: smarca4/2 loss inhibits chemotherapy-induced apoptosis by restricting ip3r3-mediated ca(2+) flux to mitochondria
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030806/
https://www.ncbi.nlm.nih.gov/pubmed/36944611
http://dx.doi.org/10.1038/s41467-023-37144-1
work_keys_str_mv AT xueyibo authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT morrisjordanl authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT yangkangning authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT fuzheng authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT zhuxianbing authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT johnsonfraser authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT meehanbrian authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT witkowskileora authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT yasmeenamber authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT golenartunde authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT coathammackenzie authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT moringenevieve authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT monastanie authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT pilonvirginie authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT fisetpierreolivier authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT jungsungmi authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT gonzalezannev authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT camilleribroetsophie authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT fulili authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT postovitlynnemarie authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT spicerjonathan authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT gotliebwalterh authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT guiotmariechristine authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT rakjanusz authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT parkmorag authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT lockwoodwilliam authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT foulkeswilliamd authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT prudentjulien authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria
AT huangsidong authorcorrectionsmarca42lossinhibitschemotherapyinducedapoptosisbyrestrictingip3r3mediatedca2fluxtomitochondria